7th CML-CAB: Amsterdam, The Netherlands, 3-5 March 2019

On 3-5 March 2019, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted its 7th meeting to discuss issues of major concern to the CML community.

CML-CAB Members attending the 7th CML-CAB as patient experts:

• Jan Geissler - Germany- (CML-CAB Co-chair) 
• Pat Garcia-Gonzalez - (CML-CAB Co-chair)
• Giora Sharf – Israel and Europe
• Jana Pelouchova - Czech Republic and Central Eastern Europe
• Bahija Gouimi - Africa and the Middle East 
• Rita Christensen - Western Europe
• Rod Padua - East Asia and Pacific 
• Felice Bombaci – Italy & Western Europe
• Šarūnas Narbutas – CML AN Chair - Eastern Europe 
• Mercedes Arteaga, - Latin America
• Yair Bar David (Israel)
• Cornelia Borowczak, Germany Pediatric CML
• Zack Pemberton-Whiteley, United Kingdom & West Europe
• Yong Yoke Choon, Malaysia & Asia

Plus, the CML Advocates Network team Lidija Pecova and Celia Marín.

CML-CAB with Pfizer, Monday 4th March 2019, 14:00 – 18:00

The following topics were discussed during the CML-CAB:

• Pfizer’s Updates: Organization & CML Strategy
• Access
• Bosulif Patient Experience 
• TFR Patient Survey Update 
• Discussion and Next Steps 

Non-confidential minutes of the meeting are available to CML Advocates Network members below:

pdf 7th CMLCAB March 2019 Pfizer Minutes Non-confidential (686 KB)

CML-CAB with Incyte/Takeda 5th March 2019, 08:00 – 15:00

The following topics were discussed during the CML-CAB:

• Collaboration between the CML community and Takeda/Incyte & Partners
• Review of priority projects/engagements lead by Incyte with support of the CML community
• Ponatinib –Access, clinical application and research
• Takeda Commitment to CML, Discussion and Next Steps 

Non-confidential minutes of the meeting are available to CML Advocates Network members below.

pdf 7th CML CAB March 2019 Incyte and Takeda Minutes Non-confidential (707 KB)